(Q44958309)

English

Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

0 references

hospitalization

1 reference

based on heuristic

inferred from title

author name string

John Edelsberg

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Ariel Berger

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

David J Weber

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Rajiv Mallick

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Andreas Kuznik

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Gerry Oster

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

1 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Infection Control and Hospital Epidemiology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

160-169

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000)

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Newer treatment options for skin and soft tissue infections

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

A severity score for complicated skin and soft tissue infections derived from phase III studies of linezolid

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Cost of care for inpatients with community-acquired intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Practice guidelines for the diagnosis and management of skin and soft-tissue infections

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Maximizing efficacy and reducing the emergence of resistance

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use.

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Grou

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

A practical guide to the treatment of complicated skin and soft tissue infections

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Clinical presentations of soft-tissue infections and surgical site infections

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Effect of Linezolid versus Vancomycin on Length of Hospital Stay in Patients with Complicated Skin and Soft Tissue Infections Caused by Known or Suspected Methicillin-Resistant Staphylococci: Results from a Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Ertapenem once daily versus piperacillin-tazobactam 4 times per day for treatment of complicated skin and skin-structure infections in adults: results of a prospective, randomized, double-blind multicenter study

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Survival in patients with nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome.

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance

1 reference

https://api.crossref.org/works/10.1086%2F526444

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44958309&oldid=2059513497"